Clinical Significance of Albumin- and Bilirubin-Based Biomarkers in Glaucoma: A Retrospective Case-Control Study

Table 2

Demographics and parameters of glaucoma patients with PACG and POAG.

	PACG	POAG	value
n	105	70	—
Age, y	64 (55 70)	60 (54 72)	0.8523
Glaucoma severity
Early	22	19	0.6172
Moderate	41	24
Severe	42	27
NEU (10^9/L)	4.1 (3.4 5.1)	3.7 (3.1 4.7)	0.1490
TP (g/L)	71.2 (67.7 74.4)	72.5 (69.9 74.8)	0.0845
ALB (g/L)	43.4 (42.1 45.2)	44.0 (42.0 45.3)	0.7058
GLB (g/L)			0.4336
TBIL (mol/L)	15.2 (12.3 19.)	15.8 (12.5 19.0)	0.4985
DBIL (mol/L)	5.2 (3.9 6.3)	5.3 (4.2 6.6)	0.4765
IBIL (mol/L)	10.1 (7.9 12.4)	10.3 (7.8 13.2)	0.7194
NAR	0.092 (0.078 0.116)	0.086 (0.071 0.111)	0.1363
NTBR	0.279 (0.195 0.371)	0.215 (0.168 0.322)	0.1043
NIBR	0.421 (0.280 0.572)	0.342 (0.248 0.495)	0.1254

Data are presented as median (IQR) except for GLB, which is presented as . Kolmogorov-Smirnov test was performed for checking data normality. The differences of all parameters between patients with PACG and POAG were examined by Mann–Whitney test, except for disease severity and GLB, which was examined by Chi-square test and unpaired Student’s test (two-tailed), respectively. was considered statistically significant.